Capital Fund Management (CFM)’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Capital Fund Management (CFM)’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-19,683	Closed	-$393K	–	1847
2021 Q2	$393K	Sell	19,683 -35,677	-64%	-$707K	﹤0.01%	1334
2021 Q1	$1.28M	Buy	55,360 +28,272	+104%	+$788K	0.01%	900
2020 Q4	$669K	Buy	+27,088	New	+$898K	0.01%	1082
2020 Q1	–	Sell	-9,996	Closed	-$898K	–	2136
2019 Q4	$1.24M	Buy	+9,996	New	+$895K	0.01%	1016
2019 Q3	–	Sell	-11,689	Closed	-$785K	–	1955
2019 Q2	$930K	Buy	+11,689	New	+$1.05M	0.01%	1036
2019 Q1	–	Sell	-8,473	Closed	-$854K	–	2188
2018 Q4	$854K	Buy	+8,473	New	+$878K	0.01%	1149
2018 Q2	–	Sell	-6,546	Closed	-$403K	–	2344
2018 Q1	$403K	Buy	+6,546	New	+$395K	﹤0.01%	1529
2016 Q4	–	Sell	-4,142	Closed	-$493K	–	1914
2016 Q3	$682K	Buy	+4,142	New	+$653K	0.01%	1093
2016 Q2	–	Sell	-3,154	Closed	-$460K	–	1848
2016 Q1	$405K	Buy	+3,154	New	+$372K	﹤0.01%	1225
2015 Q3	–	Sell	-3,363	Closed	-$812K	–	1732
2015 Q2	$812K	Buy	3,363 +1,720	+105%	+$458K	0.01%	889
2015 Q1	$463K	Sell	1,643 -32,518	-95%	-$7.04M	0.01%	1075
2014 Q4	$5.33M	Buy	+34,161	New	+$6.31M	0.06%	418
2014 Q3	–	Sell	-24,673	Closed	-$5.84M	–	1884
2014 Q2	$5.84M	Buy	+24,673	New	+$6.5M	0.06%	386

Other funds holding ICPT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

EAM

EULAV Asset Management Sarasota, Florida $3.12B AUM 13.38% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Fund Management (CFM)'s ICPT Position: Q3 2021 in Review

Capital Fund Management (CFM) sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2021, closing a stake of 19,683 shares — an estimated $393K sold.

Capital Fund Management (CFM) first reported a position in ICPT in Q2 2014 and held it in 13 quarters. The position peaked at $5.84M in Q2 2014. 139 funds tracked by Wall St. Rank hold ICPT as of Q3 2021.

Capital Fund Management (CFM) reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Capital Fund Management (CFM) sold 19,683 Intercept Pharmaceuticals, Inc. shares in Q3 2021, an estimated $393K.
Capital Fund Management (CFM) first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and held it in 13 quarters.
Capital Fund Management (CFM)'s Intercept Pharmaceuticals, Inc. position peaked at $5.84M in Q2 2014.
139 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2021.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2021, filed 12 Nov 2021.